UroGen Pharma Reports Third Quarter 2023 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/14/2026

1. IBM
2. JPM
3. SPY
4. ERAS
5. TREX
6. BAC
7. SPCX
8. WFC
9. BIIB
10. SPRO

Go back to UroGen Pharma Reports Third Quarter 2023 Financial Results
(NASDAQ: URGN) Delayed: 39.81 +0.30 (0.76%)
Previous Close $39.51    52 Week High $ 
Open $39.53    52 Week Low $ 
Day High $39.99    P/E N/A 
Day Low $38.88    EPS $ 
Volume 130,731